Connecticut residents may have to wait until 2023 to access the state’s adult-use cannabis market.
Under state law, adult-use cannabis sales cannot begin in the state of Connecticut until there is at least 250,000 square feet of growing and manufacturing space approved for adult-use production. Thus far, the following producers have been approved for adult-use operations: Advanced Grow Labs LLC, Connecticut Pharmaceutical Solutions LLC and Curaleaf LLC. The fourth and final producer, Theraplant, did not apply for adult-use approval until November 10, 2022. As a result, industry experts do not expect that all four producers will be available until 2023.
“The Department’s priority is to have a safe, well-regulated marketplace for consumers,” Connecticut Department of Consumer Protection Michelle H. Seagull said.
“I am grateful to the Drug Control and Legal teams at DCP who have worked—and continue to work—tirelessly, since the passage of the law, toward a safe and successful market opening.”
When all four producers are ready to supply cannabis to residents and visitors across the state, the following dispensaries have received approval to sell cannabis for recreational use: Affinity, Bluepoint Wellness of Connecticut, C3 Torrington, FDD Newington, FDD Stamford, FDD Willimantic and Willow Brook Wellness.
